Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study

Saved in:
Bibliographic Details
Published in:Neurology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867664056296407040
collection WordPress RSS
FRELIP Feed Integration
container_title Neurology and Therapy
description
discipline_display Psychiatry and Neurology
discipline_facet Psychiatry and Neurology
format Online Article
RSS Article
genre Journal Article
id rss_article:89565
institution FRELIP
journal_source_facet Neurology and Therapy
last_indexed 2026-06-11T02:00:41.891Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
Psychiatry and Neurology
General
Psychiatry and Neurology
sub_discipline_display General
sub_discipline_facet General
subject_display Psychiatry and Neurology
General
Psychiatry and Neurology
Psychiatry and Neurology
General
Psychiatry and Neurology
subject_facet Psychiatry and Neurology
General
Psychiatry and Neurology
title Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
title_auth Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
title_full Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
title_fullStr Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
title_full_unstemmed Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
title_short Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
title_sort real-world response and super-response to eptinezumab over 48 weeks in migraine: the prospective multicenter embrace iii study
topic Psychiatry and Neurology
General
Psychiatry and Neurology
url https://link.springer.com/article/10.1007/s40120-026-00971-7